NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Fermi Inc. ("Fermi Inc." or the "Company") (NASDAQ: FRMI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Fermi Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Fermi: (a) common stock pursuant and/or traceable to the registration statement and prospectus i ...

NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Oracle Corporation ("Oracle" or the "Company") (NYSE: ORCL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Oracle investors who were adversely affected by alleged securities fraud between June 12, 2025 and December 16, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/oracle-corporation-lawsuit-su ...

Broad Arrow set to offer incredibly original, matching-numbers, fully evolved 1972 Lamborghini Miura P400 SV at company’s fourth annual Amelia Concours Auction | Set for March 6-7 at the Ritz-Carlton, Amelia Island, the two-day sale is the official auction of the renowned Amelia Concours | Supercars then and now: Remarkable example of the original supercar is offered alongside desirable modern supercars and hypercars including a 2008 Bugatti Veyron EB 16.4 Coupe, a 1988 Porsche 959 SC Reimagined by Canepa, ...

NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Ramaco Resources, Inc. ("Ramaco" or the "Company") (NASDAQ: METC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ramaco investors who were adversely affected by alleged securities fraud between July 31, 2025 and October 23, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/ramaco-resources-inc-law ...

NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Ardent Health, Inc. ("Ardent Health, Inc." or the "Company") (NYSE: ARDT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ardent Health, Inc. investors who were adversely affected by alleged securities fraud between July 18, 2024 and November 12, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/ar ...

NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Beyond Meat, Inc. ("Beyond Meat, Inc." or the "Company") (NASDAQ: BYND) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Beyond Meat, Inc. investors who were adversely affected by alleged securities fraud between February 27, 2025 and November 11, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/be ...

NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of common stock of Masonite International Corporation (NYSE: DOOR) between June 5, 2023 and February 8, 2024, inclusive (the “Class Period”), of the important April 7, 2026 lead plaintiff deadline. SO WHAT: If you sold Masonite common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT ...

NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in BellRing Brands, Inc. (NYSE: BRBR) that a class action lawsuit has been filed on behalf of shareholders who purchased securities between November 19, 2024 and August 4, 2025. The convenient nutrition industry has experienced explosive growth in recent years, with ready-to-drink protein shakes expanding from a niche fitness product into a mainstream consumer category generating billions in annual revenue. BellRing capture ...

NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Kyndryl Holdings, Inc. ("Kyndryl" or the "Company") (NYSE: KD) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Kyndryl investors who were adversely affected by alleged securities fraud between August 7, 2024 and February 9, 2026. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/kyndryl-holdings-lawsuit- ...

Core Viewpoint - A class action lawsuit has been filed against Inovio Pharmaceuticals, alleging that the company concealed manufacturing deficiencies related to its CELLECTRA device, which is crucial for its DNA medicine platform, leading to significant delays in the Biologics License Application submission timeline [1][2][3]. Group 1: Allegations of Manufacturing Deficiencies - The lawsuit claims that Inovio represented its CELLECTRA devices as "validated and manufactured under Current Good Manufacturing Practices (cGMP)" while allegedly hiding manufacturing issues with the single-use disposable administration component [2][4]. - A specific manufacturing issue was identified during routine testing, which is said to have stemmed from a plastic molded part within the array component [4][7]. Group 2: Impact on Biologics License Application (BLA) - The complaint alleges that these manufacturing deficiencies caused a full-year delay in the BLA submission timeline, moving the projected submission from the second half of 2024 to mid-2025 [3][7]. - Retesting of the CELLECTRA device was required due to these issues, further extending the timelines for the BLA submission [7]. Group 3: Importance of Accurate Disclosure - The integrity of the CELLECTRA device is deemed critical to Inovio's commercial transition, making accurate disclosure of its manufacturing status essential for investors [4]. - The case raises significant questions regarding manufacturing disclosure obligations within the biotechnology sector, highlighting the importance of transparency for investor trust [5].